# AI production-readiness gap assessment

The requested “10/10 production-ready” objective is not complete and must not
be represented as complete.

## Engineering status

- Model training, provenance, versioning, and lifecycle controls exist in the
  isolated wysh.AI research path.
- Persistent clinician review, authorization, and redacted audit controls
  exist for synthetic drafts.
- R17 ML operations contracts now cover deterministic A/B assignment,
  validation metrics, multi-feature drift monitoring with minimum-sample
  safeguards, versioned/hash-chained drift-review records with replay
  rejection, drift-triggered retraining review, native linear attribution, and
  hashed inference audit records.
- SHAP/LIME are `NOT_CONFIGURED`; native attribution is not equivalent to
  SHAP/LIME and does not establish clinical explainability.

## Not complete

- Release Gate 7 clinical safety/validation is not passed for clinical use.
- Clinical outcome tracking and false-positive/false-negative rates require
  qualified reference standards and permitted data; current synthetic metrics
  remain engineering-only or insufficient-sample.
- Sustained-load drift monitoring and automated retraining execution are not
  authorized. Drift only creates `RETRAINING_REVIEW_REQUIRED`; the monitor
  records the model/version and aggregate feature results for qualified review.
- WyshCare `backend/src/modules/ml/` was not modified because WyshCare is
  outside the authorized write scope.

Clinical governance remains `HOLD`, clinical validation and production remain
`NO-GO`, and the evidence-backed score remains 69/100.
